Prognosis Factors of Patients Undergoing Renal Replacement Therapy
Journal of Personalized Medicine · 30.03.2023 · 13 (4) · 605
DOI: 10.3390/jpm13040605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 30.03.2023. Verfasst von José Manuel Muñoz-Terol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Survival in patients with end-stage kidney disease (ESKD) on renal replacement therapy (RRT) is less than that of the general population of the same age, and depends on patient factors, the medical care received, and the type of RRT used. The objective of this study is to analyze the factors associated with survival in patients undergoing RRT.
Methods
We conducted a retrospective observational study of adult patients with an incident of ESKD on RRT in Andalusia from 1 January 2008 to 31 December 2018. Patient characteristics, nephrological care received, and survival from the beginning of RRT were evaluated. A survival model for the patient was developed according to the variables studied.
Results
A total of 11,551 patients were included. Median survival was 6.8 years (95% CI (6.6; 7.0)). After starting RRT, survival at one year and five years was 88.7% (95% CI (88.1; 89.3)) and 59.4% (95% CI (58.4; 60.4)), respectively. Age, initial comorbidity, diabetic nephropathy, and a venous catheter were independent risk factors. However, non-urgent initiation of RRT and follow-up in consultations for more than six months had a protective effect. It was identified that renal transplantation (RT) was the most influential independent factor in patient survival, with a risk ratio of 0.13 (95% CI (0.11; 0.14)).
Conclusions
The receiving of a kidney transplant was the most beneficial modifiable factor in the survival of incident patients on RRT. We consider that the mortality of the renal replacement treatment should be adjusted, taking into account both modifiable and nonmodifiable factors to achieve a more precise and comparable interpretation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain.
- Department of Medicine, University of Seville, 41009 Seville, Spain.
- Information System of the Autonomic Transplant Coordination of Andalusia (SICATA), 41013 Seville, Spain.
- Neurocritical Care Unit, Hospital Universitario Virgen del Rocío, 41013 Seville, Spain.
- Institute of Biomedicine of Seville (IBiS)/Consejo Superior de Investigaciones Científicas (CSIC), University of Seville, 41013 Seville, Spain.
- Preventive Medicine and Public Health Department, University of Seville, 41009 Seville, Spain.
ORCID-Profile: José L Rocha, Juan José Egea-Guerrero, Emilio García-Cabrera, Angel Vilches-Arenas
Zitieren
APA
Muñoz-Terol, J. M., Rocha, J. L., Castro-de la Nuez, P., Egea-Guerrero, J. J., Gil-Sacaluga, L., García-Cabrera, E., & Vilches-Arenas, A. (2023). Prognosis Factors of Patients Undergoing Renal Replacement Therapy. Journal of Personalized Medicine, 13(4), 605. https://doi.org/10.3390/jpm13040605
Vancouver
Muñoz-Terol JM, Rocha JL, Castro-de la Nuez P, Egea-Guerrero JJ, Gil-Sacaluga L, García-Cabrera E, et al. Prognosis Factors of Patients Undergoing Renal Replacement Therapy. Journal of Personalized Medicine. 2023;13(4):605. doi:10.3390/jpm13040605
BibTeX
@article{MuozTerol2023,
author = {Muñoz-Terol, José Manuel and Rocha, José L and Castro-de la Nuez, Pablo and Egea-Guerrero, Juan José and Gil-Sacaluga, Luis and García-Cabrera, Emilio and Vilches-Arenas, Angel},
title = {Prognosis Factors of Patients Undergoing Renal Replacement Therapy},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {4},
pages = {605},
doi = {10.3390/jpm13040605}
}
EUVIMED